Full metadata record
DC FieldValueLanguage
dc.creatorParamo, J.A. (José Antonio)-
dc.creatorRodriguez, J.A. (José Antonio)-
dc.creatorOrbe, J. (Josune)-
dc.date.accessioned2012-05-28T15:14:05Z-
dc.date.available2012-05-28T15:14:05Z-
dc.date.issued2007-
dc.identifier.citationParamo JA, Rodriguez Ja JA, Orbe J. Integrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patients. Biomark Insights 2007 Feb 7;1:165-173.es_ES
dc.identifier.issn1177-2719-
dc.identifier.urihttps://hdl.handle.net/10171/22245-
dc.description.abstractThe clinical utility of a biomarker depends on its ability to identify high-risk individuals to optimally manage the patient. A new biomarker would be of clinical value if it is accurate and reliable, provides good sensitivity and specificity, and is available for widespread application. Data are accumulating on the potential clinical utility of integrating imaging technologies and circulating biomarkers for the identification of vulnerable (high-risk) cardiovascular patients. A multi-biomarker strategy consisting of markers of inflammation, hemostasis and thrombosis, proteolysis and oxidative stress, combined with new imaging modalities (optical coherence tomography, virtual histology plus IVUS, PET) can increase our ability to identify such thombosis-prone patients. In an ideal scenario, cardiovascular biomarkers and imaging combined will provide a better diagnostic tool to identify high-risk individuals and also more efficient methods for effective therapies to reduce such cardiovascular risk. However, additional studies are required in order to show that this approach can contribute to improved diagnostic and therapeutic of atherosclerotic disease.es_ES
dc.language.isoenges_ES
dc.publisherLibertas Academicaes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectBiomarkerses_ES
dc.subjectAtherosclerosises_ES
dc.subjectInflammationes_ES
dc.subjectVulnerable plaquees_ES
dc.subjectProteolysises_ES
dc.subjectMetalloproteinaseses_ES
dc.titleIntegrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patientses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttp://bit.ly/Jx9M81es_ES
dc.type.driverinfo:eu-repo/semantics/articlees_ES

Files in This Item:
Thumbnail
File
BiomarkerInsights2006_165.pdf
Description
Size
890.67 kB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.